Drug Therapy
- Statin intolerance and new lipid-lowering treatments
The benefits and safety of statin therapy are clear, but adverse effects continue to pose diagnostic and therapeutic challenges.
What antithrombotic therapy should I use for my patient with atrial fibrillation who underwent percutaneous coronary intervention or had an acute coronary syndrome?The risk of thrombosis should be balanced with the risk of bleeding.
- The current state of tobacco cessation treatment
Behavioral interventions and pharmacotherapy increase success rates. Alternative treatments should not replace or delay the use of known effective therapies.
- Promoting physical activity in older women to maximize health
The optimal type, intensity, and level required to achieve specific health outcomes depend on the disease the patient and clinician are trying to prevent or manage.
- Evolving distal signs
The patient’s evolving signs and symptoms prompted a reconsideration of his diagnosis.
- Famous and not-so-famous physical findings in infectious endocarditis: A look back
It is difficult to find a disease more emblematic of the practice of internal medicine.
- Dual antiplatelet therapy after percutaneous coronary intervention: Personalize the duration
A review of current guidelines on the duration of therapy and perioperative management.
- Medical complications of bulimia nervosa
Complications can affect all body systems, but especially the renal and electrolyte systems.
- Is it safe to start steroids at home for a COPD exacerbation after virtual assessment in the COVID-19 era?
Yes. Corticosteroids are beneficial, and virtual visits are appropriate, especially in this pandemic.
- Our evolving understanding of primary aldosteronism
Current screening and confirmatory testing lack sensitivity and carry a poor negative predictive value.